Advances in Bone & Joint Health

Bio-Replenishment:  A new approach to supplementation
 
Leave the planning to us!

Clinical Studies

ELS Clinical Evaluation 
September 1, 2007
ELS (Enriched Lactoferrin Supplementation) showed 25% reduction of bone resorption and 43% increase in bone formation markers in two weeks





Osteoporosis International
January 27th, 2009
R-ELF reduces bone loss and increases bone formation

          

 

 

 

 

 
Inflammation Research
May 2010
R-ELF shows beneficial effects on inflammatory status

 







Bone Density Studies
Underway in Europe
(1,000+ patients to date)



For additional studies, go to http://www.nterminus.com/





 

 

 

 

 

 

 

 

 

 

The studies listed above are a matter of public record.  The statements contained herein are not intended nor should be misconstrued for the purpose of diagnosing or treatment of any medical condition.  There is no warranty expressed or implied by these materials.  

The statements made on this website have not been evaluated by the FDA (U.S. Food & Drug Administration).  The products herein are not intended to diagnose, cure or prevent any disease.  If a condition persists, please contact your physician. The information provided by this website is not a substitute for a face-to-face consultation with your physician and should not be construed as individual medical advice.

The testimonials on this website are individual cases and do not guarantee that you will have similar results.


Case Reports        Solution        Testimonials 

Web Hosting Companies